XOMA Royalty Names Jeffrey Trigilio Finance Chief as Thomas Burns Departs

Dow Jones
01/12
 

By Colin Kellaher

 

XOMA Royalty's top finance executive, Thomas Burns, is leaving the biotechnology royalty aggregator to pursue other opportunities.

XOMA on Monday said Jeffrey Trigilio, who most recently served as chief financial and operating officer of Obsidian Therapeutics, will succeed Burns as chief financial officer of the Emeryville, Calif., company.

Burns, who joined XOMA in August 2006, has been senior vice president of finance and finance chief since March 2017.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

January 12, 2026 07:50 ET (12:50 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10